News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,031 Results
Type
Article (87764)
Company Profile (824)
Press Release (778427)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233173)
Career Advice (4143)
Deals (39836)
Drug Delivery (144)
Drug Development (91360)
Employer Resources (203)
FDA (18358)
Job Trends (17414)
News (397714)
Policy (39949)
Tag
Academia (3006)
Academic (2)
Accelerated approval (26)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (170)
Alzheimer's disease (1761)
Antibody-drug conjugate (ADC) (304)
Approvals (18468)
Artificial intelligence (579)
Autoimmune disease (134)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (488)
Bladder cancer (150)
Brain cancer (61)
Breast cancer (622)
Cancer (4693)
Cardiovascular disease (409)
Career advice (3565)
Career pathing (40)
CAR-T (290)
CDC (59)
Celiac Disease (1)
Cell therapy (787)
Cervical cancer (36)
Clinical research (76559)
Collaboration (1603)
Company closure (5)
Compensation (1068)
Complete response letters (65)
COVID-19 (2979)
CRISPR (93)
C-suite (741)
Cystic fibrosis (147)
Data (5840)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (495)
Diagnostics (7170)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (272)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (224)
Earnings (99892)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134515)
Executive appointments (1009)
FDA (21224)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1435)
Gene editing (202)
Generative AI (60)
Gene therapy (627)
GLP-1 (1082)
Government (5419)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (276)
Immuno-oncology (41)
Indications (76)
Infectious disease (3249)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (95)
Longevity (14)
Lung cancer (647)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (749)
MASH (165)
Medical device (14971)
Medtech (15011)
Mergers & acquisitions (22879)
Metabolic disorders (1292)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2961)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (61)
Obesity (621)
Opinion (326)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (201)
Parkinson's disease (272)
Partnered (34)
Patents (470)
Patient recruitment (404)
Peanut (58)
People (66634)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23638)
Phase II (33229)
Phase III (25049)
Pipeline (3895)
Policy (319)
Postmarket research (3554)
Preclinical (10666)
Press Release (72)
Prostate cancer (229)
Psychedelics (53)
Radiopharmaceuticals (289)
Rare diseases (806)
Real estate (7436)
Recruiting (80)
Regulatory (28571)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (236)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4326)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (116)
Vaccines (1107)
Venture capital (79)
Weight loss (433)
Women's health (79)
Worklife (21)
Date
Today (71)
Last 7 days (640)
Last 30 days (2606)
Last 365 days (33306)
2025 (32567)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (326)
Arkansas (14)
Asia (51317)
Australia (9018)
California (10821)
Canada (3172)
China (1055)
Colorado (455)
Connecticut (481)
Delaware (324)
Europe (117972)
Florida (1583)
Georgia (350)
Hawaii (3)
Idaho (68)
Illinois (892)
India (62)
Indiana (522)
Iowa (22)
Japan (377)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1396)
Massachusetts (8017)
Michigan (342)
Minnesota (627)
Mississippi (6)
Missouri (134)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2949)
New Mexico (32)
New York (2893)
North Carolina (1535)
North Dakota (10)
Northern California (5101)
Ohio (330)
Oklahoma (22)
Oregon (52)
Pennsylvania (2192)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4156)
Tennessee (167)
Texas (1701)
United States (39356)
Utah (323)
Vermont (1)
Virginia (271)
Washington D.C. (85)
Washington State (915)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
There are 867,031 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
December 17, 2025
·
4 min read
Press Releases
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
December 17, 2025
·
5 min read
Press Releases
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas
December 17, 2025
·
4 min read
Press Releases
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics’ Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
December 17, 2025
·
4 min read
Press Releases
Alnylam Announces Health Canada Approval of AMVUTTRA® (vutrisiran), the First and Only RNAi Therapeutic for the Treatment of Cardiomyopathy in Adult Patients with ATTR Amyloidosis
December 17, 2025
·
10 min read
Press Releases
Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1
December 17, 2025
·
6 min read
Press Releases
British Columbia reimburses FRUZAQLATM (fruquintinib capsules) for the treatment of metastatic colorectal cancer (mCRC)
December 17, 2025
·
5 min read
Press Releases
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
December 17, 2025
·
5 min read
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
·
4 min read
Press Releases
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 17, 2025
·
1 min read
1 of 86,704
Next
